Myasthenia gravis

97
MYAS THENIA G RAVIS BY V ARDAN AR ORA

Transcript of Myasthenia gravis

Page 1: Myasthenia gravis

MYA

STHENIA G

RAVIS

B

Y VARDAN

ARORA

Page 2: Myasthenia gravis

SYNOPSIS

INTRODUCTIONGROSS ANATOMY OF ARMHISTO-ANATOMY OF ARMPHYSIO OF SKELETAL MUSCLESIGNS & SYMPTOMSPATHOPHYSIOLOGY OF MGDIAGNOSISMANAGEMENTPROGNOSISREFERENCES

Page 3: Myasthenia gravis

INTRODUCTION The word MYASTHENIA GRAVIS is

derived from Greek & Latin Greek: myasthenia: muscle weakness Latin:gravis: serious

Page 4: Myasthenia gravis

Mg is an autoimmune neuromuscular disease, leading to fluctuating muscle weakness & fatigue

Page 5: Myasthenia gravis

MG WEAKNESS In MG weakness is caused by

circulating antibodies that block acetylcholine receptors at the postsynaptic neuromuscular junction, inhibiting the excitatory effects of the neurotransmitter acetylcholine on nicotinic receptors throughout neuromuscular junctions.

Page 6: Myasthenia gravis

Myasthenia gravis: It affects people of any age, it's

more common in women younger than 40 and in men older than 60

The disease incidence is 3–30 cases per million per year and rising as a result of increased awareness.

Page 7: Myasthenia gravis

NEONATAL MYASTHENIA:  If a woman with myasthenia

gravis gives birth, the baby may have some temporary, and potentially life-threatening, muscle weakness (neonatal myasthenia) because of antibodies that have transferred from the mother's bloodstream.

Page 8: Myasthenia gravis

Typically, during the baby's first weeks of life, the antibodies are cleared from the baby's circulation and the baby develops normal muscle tone and strength.

Page 9: Myasthenia gravis

GROSS ANATOMY OF

THE ARM

Page 10: Myasthenia gravis

MUSCLES OF THE ARM Biceps Brachii

Triceps Brachii

Brachialis

Anconeus

Brachiorradialis

Coracobrachialis

Page 11: Myasthenia gravis

BICEPS BRACHIIOrigin • short head: coracoid process of the scapula• long head: supraglenoid tubercle of the scapula

Insertion• tuberosity of the radius

Action flexes the forearm, flexes arm (long head), supinates

Page 12: Myasthenia gravis

anatomy.uams.edu/anatomyhtml/gross_atlas.htm

Page 13: Myasthenia gravis

BRACHIALISOrigin• anterior surface of the lower one-half of the

humerus and the associated intermuscular septa

Insertion• coronoid process of the ulna

Action flexes the elbow, assists in pronation &

supination

Page 14: Myasthenia gravis

anatomy.uams.edu/anatomyhtml/gross_atlas.htm

Page 15: Myasthenia gravis

Coracobrachialis

Origin Coracoid process of the scapula

Insertion medial side of the humerus at mid-shaft

Action flexes and adducts the arm

Page 16: Myasthenia gravis
Page 17: Myasthenia gravis

Triceps BrachiiOrigin•long head: infraglenoid tubercle of the scapula•lateral head: posterolateral humerus & lateral intermuscular septum•medial head: posteromedial surface of the inferior 1/2 of the humerus

Insertion•olecranon process of the ulna

Actionextends the forearm, the long head extends and adducts arm

Page 18: Myasthenia gravis

anatomy.uams.edu/anatomyhtml/gross_atlas.htm

Page 19: Myasthenia gravis

Anconeus

Origin•lateral epicondyle of the humerus

Insertion•lateral side of the olecranon and the upper one-fourth of the ulna

Action•extends the forearm

Page 20: Myasthenia gravis

anatomy.uams.edu/anatomyhtml/gross_atlas.htm

Page 21: Myasthenia gravis

NERVES OF THE ARM Nerves that supply the arm are branches of

the brachial plexus.

There are five main nerves from the brachial plexus, these nerves are;AxillaryUlnarMedianMusculocutaneousRadial

Page 22: Myasthenia gravis

However, there are two main nerves that supply the Arm. These nerves are;

Musculocutaneous nerve Radial Nerve

Page 23: Myasthenia gravis

MUSCULOCUTANEOUS NERVE It’s a mixed nerve , it has both sensory and

motor function. Its root value is C5,C6,C7 It arises from the lateral cord The musculocutaneous nerve leaves the

brachial plexus sheath high in the axilla at the level of the lower border of the teres major muscle and passes into the coracobrachialis muscle.

It innervates the muscles in the flexor compartment of the arm and carries sensation from the lateral (radial) side of the forearm

Its responsible for the biceps jerk (C5,C6) (Stephen et al, 2013)

Page 24: Myasthenia gravis

http://emedicine.medscape.com/article/1877731-overview#showall

Page 25: Myasthenia gravis

RADIAL NERVE It is derived from the posterior cord

Its root value is C5,C6,C7,C8,C9,T1

The nerve passes out of the axilla posteriorly and supplies branches to the long and medial heads of the triceps brachii.

It has both sensory and motor function

Page 26: Myasthenia gravis

Sensory; Innervates most of the skin of the posterior side of forearm, and the dorsal surface of the lateral side of the palm, and lateral three and a half digits

Motor;  Innervates the triceps brachii, responsible for extension at the elbow.

Innervates the majority of the extensor muscles in the forearm, responsible for extension of wrist and fingers and supination of the forearm (Oliver, 2013)

Page 27: Myasthenia gravis

http://emedicine.medscape.com/article/1877731-overview#showall

Page 28: Myasthenia gravis

SKELETAL MUSCLE

A skeletal muscle consists of muscle fibres held together by connective tissue (collagenous fibres).(Hill,2013)

Skeletal muscle constitutes the muscle that is attached to the skeleton and controls motor movements and posture. There are a few instances where this type of muscle is restricted to soft tissues: the tongue, pharynx, diaphragm and upper part of the esophagus

Page 29: Myasthenia gravis

DIAGRAM OF SKELETAL MUSCLE

Page 30: Myasthenia gravis

SKELETAL MUSCLELONGITUDINAL SECTION

TRANSVERS SECTION

Page 31: Myasthenia gravis

SKELETAL MUSCLE-ITS EMBRYOGENESIS

Skeletal muscle fibres (cells) are actually a multinucleated syncytium formed by the fusion of individual small muscle cells(myoblasts), during development. They’re filled with longitudinally arrayed subunits(myofibrils). The myofibrils are made up of the myofilaments myosin (thick filaments) and actin (thin filaments).

The striations reflect the arrangement of actin and myosin filaments and support structures. The individual contractile units are called sarcomeres.

A myofibril consists of many sarcomeres arranged end to end. The entire muscle exhibits cross-striations because sarcomeres in adjacent myofibrils and muscle fibers are in register

Page 32: Myasthenia gravis

. The most obvious feature in longitudinal sections of skeletal muscle is the alternating pattern of dark and light bands, A (anisotropic) and I (isotropic) band.

The I band is bisected by a dense zone called the Z line, to which the thin filaments of the I band are attached. The nuclei are located peripherally, immediately under the plasma membrane (sarcolemma),(mark,2013)

Page 33: Myasthenia gravis

. Individual muscle fibres are surrounded by a delicate layer of reticular fibres(endomysium). Groups of fibres are bundled into fascicles by a thicker CT layer(perimysium). The collection of fascicles that constitutes one muscle is surrounded by a sheath of dense CT(epimysium) which continues into the tendon. Blood vessels and nerves are found in the CT associated with muscle. The endomysium contains only capillaries and the finest neuronal branches.(mark,2013)

Page 34: Myasthenia gravis

SKELETAL MUSCLE Extremely elongated Unbranched cylindrical cells Each muscle cell is called muscle fibre Numerous flattened nuclei located just

beneath the sarcolemma Shows regular striations .(Hill,2013) Sarcolemma – plasma membrane of

muscle cell Sarcoplasm (cytoplasm of muscle cell) -

myofibrils,mitochondria, T-tubules, sarcoplasmic ( smooth endoplasmic) reticulum.(HILL,2013)

Sarcosomes – mitochondria of muscles

Page 35: Myasthenia gravis

The structural subunit of the muscle fibre is the myofibril.

Myofilaments are individual filamentous polymers of myosin ( thick filaments) and actin ( thin filaments ) and its associated proteins.(Hill,2013)

Thin filaments – composed primarily of the protein actin .

each thin filament of fibrous actin ( F- actin) is a polymer formed from globular actin molecules ( G- actin)

Tropomyosin , troponin also present. Thick filaments – composed of protein

myosin.(Hill,2013) Myoglobin – is oxygen- binding protein.

Numerous in red muscle.)

Page 36: Myasthenia gravis

SKELETAL MUSCLEUNDER MICROSCOPIC

A- BAND

I-BAND

Z-LINE

Page 37: Myasthenia gravis

ORGANISATION OF SKELETAL MUSCLE Dark bands / A bands – anisotropic i.e.

birefringent in polarised light.Light band / I bands – isotropic i.e. do not

alter the plane of light. (Hill,2013) The functional subunit of the myofibril is

the sarcomere , the segment of the myofibril b/w Light I band is bisected by a dense line Z line / Z disk.

Dark A band is bisected by a light region called H band.

Bisecting the light H band is a narrow dense line called M line(Hill,2013)

Page 38: Myasthenia gravis

CONTRACTILE APPARATUS OF SKELETAL MUSCLE

Page 39: Myasthenia gravis

NORMAL SKELETAL MUSCLE

N

CS

Page 40: Myasthenia gravis

MYASTHENIA GRAVIS

Autoimmune disease Extreme muscle

weakness(Leite et.al, 2008)

In this disease , Ach receptors on sarcolemma are blocked by antibodies to the receptor protein.(Leite et.al,2008)

No. of receptor sites are reduced – weakening of muscle fiber response to nerve stimuli

Page 41: Myasthenia gravis

PHYSIOLO

GY OF S

KELETA

L

MUSCLE C

ONTRACTION

Page 42: Myasthenia gravis

CONTRACTION OF SKELETAL MUSCLE

Under voluntary control. Each skeletal muscle is innervated by a

branch of motorneurons. Action potentials are propogated along

motorneurons, leading to release of Ach at the nuromuscular junction,depolarisation of the motor end plate and initiation of action potential in the muscle fiber.

Events occuring between action potential and contraction in muscle fiber are called excitation-contraction coupling(mechanism that translates the muscle action potentialinto the production of tension).

Page 43: Myasthenia gravis
Page 44: Myasthenia gravis
Page 45: Myasthenia gravis
Page 46: Myasthenia gravis
Page 47: Myasthenia gravis

STEPS IN EXCITATION-CONTRACTION COUPLING

Step 1A nerve impulse travels down an axon

and causes the release of acetylcholinein the neuro muscular junction. Acetylecholine causes the impulse to spread across the surface of the sarcolemma.

Page 48: Myasthenia gravis

STEP 2Depolarisation of sarcolemma-influx of

Na+ and efflux of k+. The nerve impulse enters the T Tubules and Sarcoplasmic Reticulum, stimulating the release of calcium ions.

Page 49: Myasthenia gravis

STEP 3 Release of Ca ions into actin filaments.

Calcium ions combine with Troponin, shifting troponin and exposing the myosin binding sites on the actin.

Page 50: Myasthenia gravis

STEP 4 Head of myosin binds with ATP and

makes way for forming cross- bridges to actin filament.In this process ATP breaks down to ADP + Pi. The released energy activates the myosin cross bridges and results in the sliding of thin actin myofilament past the thick myosin myofilaments.

Page 51: Myasthenia gravis

STEP 5

The sliding of the myofilaments draws the Z lines towards each other, the sarcomere shortens, the muscle fibers contract and therefore muscle contracts.

Page 52: Myasthenia gravis

STEP 6 ACh is inactivated by Acetylcholinesterase,

inhibit the nerve impulse conduction across the sarcolemma.

Nerve impulse is inhibited, calcium ions are actively transported back into the Sarcoplasmic Reticulum, using the energy from the earlier ATP breakdown.

The low calcium concentration causes the myosin cross bridges to separate from the thin actin myofilaments and the actin myofilaments return to their relaxed position.

Page 53: Myasthenia gravis

SUMMARY

Page 54: Myasthenia gravis
Page 55: Myasthenia gravis

MUSCLE WEAKNESSFacial NeckLimbRespiratoryocular

PTOSIS DIPLOPLIA

FACE AND THROAT MUSCLESAltered speaking.  (DYSARTHRIA) Difficulty swallowing. (DYSPHAGIA) Problems chewing.  Limited facial expressions. 

SIGNS & SYMPTOMS

Page 56: Myasthenia gravis

PATHOPHYSIOLOGY

Page 57: Myasthenia gravis

Myasthenia gravis is caused by a problem with the transmission of nerve signals to the muscles.

It is an autoimmune condition, which means the body's immune system attacks its own tissues.

Page 58: Myasthenia gravis
Page 59: Myasthenia gravis
Page 60: Myasthenia gravis
Page 61: Myasthenia gravis
Page 62: Myasthenia gravis

Genetic factors also may be associated with myasthenia gravis.

Rarely, mothers with myasthenia gravis have children who are born with myasthenia gravis (neonatal myasthenia gravis). If treated promptly, children generally recover within two months after birth.

Page 63: Myasthenia gravis

DIAGNOSIS

Page 64: Myasthenia gravis

Diagnosis

MG can be a difficult diagnosis, as the symptoms can be subtle and hard to distinguish from both normal variants and other neurological disorders

A thorough physical examination can reveal easy fatigability

A good response to medication can also be considered a sign of autoimmune pathology.

Page 65: Myasthenia gravis

Physical examination

Muscle fatigability can be tested for many muscles. A thorough investigation includes:

•looking upward and sidewards for 30 seconds: ptosis (DROOPING OF EYELIDS) and diplopia(DOUBLE VISION)

•looking at the feet while lying on the back for 60 seconds

•keeping the arms stretched forward for 60 seconds

•ten deep knee bends

•walking 30 steps on both the toes and the heels

Page 66: Myasthenia gravis

•five sit-ups, lying down and sitting up completely

•"Peek sign": after complete initial apposition of the lid margins, they quickly (within 30 seconds) start to separate and the sclera starts to show

Page 67: Myasthenia gravis

Blood test

If the diagnosis is suspected, serology can be performed in a blood test to identify certain antibodies:

•One test is for antibodies against the acetylcholine receptor]The test has a reasonable sensitivity of 80–96%, but in MG limited to the eye muscles (ocular myasthenia) the sensitivity falls to 50% (negative in up to 50% who have MG).

•A proportion of the patients without antibodies against the acetylcholine receptor have antibodies against the Muscle protein.

Page 68: Myasthenia gravis

•In specific situations (decreased reflexes which increase on facilitation, coexisting autonomic features, suspected presence of neoplasm, especially of the lung, presence of increment or facilitation on repetitive EMG (electromyography) testing) testing is performed for

•Lambert-Eaton syndrome, in which other antibodies (against a voltage-gated calcium channel) can be found.

Page 69: Myasthenia gravis

Electrodiagnostics

Muscle fibers of patients with MG are easily fatigued, and thus do not respond as well as muscles in healthy individuals to repeated stimulation.

By stimulating a nerve-muscle motor unit with short sequences of rapid, regular electrical impulses, before and after exercising the motor unit, the fatiguability of the muscle can be measured.

This is called the repetitive nerve stimulation test. In single fiber electromyography (SFEMG), which is considered to be the most sensitive (although not the most specific) test for MG,

Page 70: Myasthenia gravis

Ice test

Applying ice to weak muscle groups characteristically leads to improvement in strength of those muscles.

Applying ice for 5 minutes to the muscles reportedly has a sensitivity and specificity of 76.9% and 98.3%, respectively, for the identification of MG.

It is thought that acetylcholinesterase is inhibited at the lower temperature and that this is the basis for this diagnostic test.

Page 71: Myasthenia gravis

The "edrophonium test" is infrequently performed to identify MG; its application is limited to those situations in which other investigations have failed to yield a conclusive diagnosis.

This test requires the intravenous administration of edrophonium chloride (Tensilon, Reversol) or neostigmine (Prostigmin), drugs that block the breakdown of acetylcholine by cholinesterase (acetylcholinesterase inhibitors) and temporarily increases the levels of acetylcholine at the neuromuscular junction.

In people with myasthenia gravis involving the eye muscles, edrophonium chloride will briefly relieve weakness.

Edrophonium test

Page 72: Myasthenia gravis

Edrophonium test

Photograph of a patient showing right partial ptosis (left picture),

Right picture: after an edrophonium test, note the improvement in ptosis.

Page 73: Myasthenia gravis

Imaging

A chest X-ray is frequently performed; it may point towards alternative diagnoses (e.g., Lambert-Eaton syndrome due to a lung tumor) and comorbidity.

It may also identify widening of the mediastinum suggestive of thymoma, but computed tomography (CT) or magnetic resonance imaging (MRI) are more sensitive ways to identify thymomas and are generally done for this reason.

MRI of the cranium and orbits may also be performed to exclude compressive and inflammatory lesions of the cranial nerves and ocular muscles.

Page 74: Myasthenia gravis

A chest CT-scan showing a thymoma (red circle)

Page 75: Myasthenia gravis

Pulmonary function test

Spirometry (lung function testing) may be performed to assess respiratory function if there are concerns about breathing adequacy.

The forced vital capacity may be monitored at intervals to detect increasing muscular weakness.

Acutely, negative inspiratory force may be used to determine adequacy of ventilation.

Severe myasthenia may cause respiratory failure due to exhaustion of the respiratory muscles.

Page 76: Myasthenia gravis

Pathological finding

Muscle biopsy is only performed if the diagnosis remains in doubt and clinical suspicion of MG persists.

Immunofluorescence shows IgG antibodies on the neuromuscular junction. (The antibody which causes myasthenia gravis does not fluoresce, but rather a secondary antibody directed against it.)

Muscle electron microscopy shows receptor infolding and loss of the tips of the folds, together with widening of the synaptic clefts. Both these techniques are currently used for research rather than diagnostically.

Page 77: Myasthenia gravis

MANAGEMENT OF MYASTHENIA

GRAVIS

Page 78: Myasthenia gravis

Specific treatment to age, overall health, and medical history and extent of the condition

No cure for MG, but the symptoms can be controlled.

MG is a life-long medical condition and the key to medically managing MG is early detection.

The goal of treatment is to prevent respiratory problems and provide adequate nutritional care to the child since the swallowing and breathing muscles are affected by this condition.

Page 79: Myasthenia gravis

TREATMENT OF MYASTHENIA GRAVIS

SHORT TERM

ANTICHOLESTERASESeg : Neostigmine PyridostigmineEPHEDRINE

PLASMAPHERESIS

IMMUNOGLOBULIN G

LONG TERM

IMMUNOSUPPRESSIVE AGENTSEg : PREDNISONE AZATHIOPRINE CYCLOPHOSPHAMIDE CYCLOSPORINS

Page 80: Myasthenia gravis

TREATMENTCholinesterase inhibitors neostigmine and pyridostigmine can

improve muscle function by slowing the natural enzyme cholinesterase that degrades acetylcholine in the motor end plate.

the neurotransmitter is therefore around longer to stimulate its receptor

Side effects, such as perspiration and diarrhea, can be countered by adding atropine

Pyridostigmine is a short-lived drug, with a half-life of about four hours.

Page 81: Myasthenia gravis

CORTICOSTEROIDSProduce rapid improvement in many Produce total remission / marked

improvement in > 75 % of patientsUsed as initial definite therapy Used as secondary treatment in who do

not respond to thymectomy / immunosuppressive therapy

Initial dose prednisone 15 – 25 mg/day increased until maximal improvement is seen or upto 50 – 60 mg/day

Page 82: Myasthenia gravis

Immunosuppressants  eg:prednisone, cyclosporin, mycophenolate 

and azathioprine Patients are commonly treated with a

combination of these drugs with an acetylcholinesterase inhibitor.

Treatments with some immunosuppressives take weeks to months before effects are noticed.

Other immunomodulating substances, such as drugs that prevent acetylcholine receptor modulation by the immune system, are currently being researched.

Page 83: Myasthenia gravis

THERAPIES Plasmapheresis This procedure is done in serious case of

myasthenia gravis This procedure uses a filtering process

similar to dialysis. Blood is routed through a machine that

removes the antibodies that are blocking transmission of signals from nerve endings to muscles' receptor sites.

However, the beneficial effects usually last only a few weeks .

Page 84: Myasthenia gravis

THERAPIESIntravenous immune globulin This therapy provides body with normal

antibodies, which alters immune system response.

It has a lower risk of side effects than do plasmapheresis and immune-suppressing therapy.

But it can take a week or two to start working and the benefits usually last less than a month or two.

Page 85: Myasthenia gravis

How antibodies against acetylcholine receptor block impulse conduction in synapse

Page 86: Myasthenia gravis

SURGERYThymectomy The surgical removal of the thymus. Thymectomy is recommended for most young

patients. It improves the disease course and can improve

remission. Thymectomy is thought to remove an antigen

source and reduce an anti-AChR antibody source. Thymectomy is performed when the disease is in

control. But in the presence of myasthenia gravis,

thymoma is the most likely diagnosis. Thymectomy may result in cure or great improvement in the myasthenia.

Page 87: Myasthenia gravis

BEHAVIORAL MODIFICATIONSDiet

• Patients may experience difficulty chewing and swallowing due to oropharyngeal weakness

• Thickened liquids are preferred, when dysphagia arises to counteract the fear of aspiration.

• Asparagus should be taken as it contains steroid-like substance.

Activity• Patients should be as active as possible but should take rest in

between.• Yoga exercises to stretch the weakened muscles should be

done.• This not only strengthens the muscles but also provides

oxygen & removes carbon dioxide from them.

Page 88: Myasthenia gravis

PATIENT TEACHING Teach patient/family disease process,

complications, and treatments Teach patient about their medications uses

dosage etc Teach medications to use with caution d/t

muscle exacerbation Beta blockers, calcium channel blockers, quinine,

quinidine, procainamide, some antibiotics, neuromuscular blocking agents

Avoid certain medications D-penicillinamine, A-interferon, botulinum toxin

Page 89: Myasthenia gravis

INSPIRATORY MUSCLE THERAPY

In patients with generalized MG, there is some evidence that a partial home program including training in diaphragmatic breathing , pursed lip breathing , and interval based IMT may improve respiratory muscle strength, chest wall mobility, respiratory pattern, and respiratory endurance

Page 90: Myasthenia gravis

+

Page 91: Myasthenia gravis

DRUGS TO BE AVOIDED IN MG

Not all patients have adverse effects

Myasthenic Weakness

exaggerated

Erythromycin

Azithromycin

Local anaestheticxylocaine

Streptomycin

CiprofloxacinLevofloxacin

OfloxacinGatifloxacin

Non depolarizing muscle relaxants –DTC,pancuronium

Propanol Atenolol

QuininineMagnesium

penicilliamine

Page 92: Myasthenia gravis

PROGNOSISWith effective treatment, patients have high possibility of a normal life expectancy, but anexception would be the presence of a malignant thymoma (whose lesser life expectancy is on account of the thymoma itself and is otherwise unrelated to the myasthenia).

Quality of life can vary depending on the severity and the cause.

Page 93: Myasthenia gravis

Drugs used to control MG either diminish in effectiveness over time (acetylcholinesterase inhibitors) or can possibly cause severe side effects of their own (immunosuppressants).

About 10% of MG patients are found to have tumors in their thymus glands, in which case a thymectomy is a very effective treatment with long-term remission.

However, most patients need treatment for the remainder of their lives, and their abilities vary greatly.

MG is not usually a progressive disease; the symptoms may fluctuate, but do not always get worse as the patient ages. For some, the symptoms decrease after a span of three to five years ( costanzo, 2012).

Page 94: Myasthenia gravis

REFERENCES…………….

Page 95: Myasthenia gravis

Oliver Jones (2013), The Radial nerve, from; http://teachmeanatomy.info/upper-limb/nerves/the-radial-nerve/

Stephen k, Jeffrey MV, Julia L (2013) The Anatomy of brachial plexus. From; http://emedicine.medscape.com/article/1877731-overview#showall

 Hill, M.A. (2013) Skeletal Muscle Histology. Retrieved October 1, 2013, from http://php.med.unsw.edu.au/embryology/index.php?title=Skeletal_Muscle_Histology

Dr Mark Hill 2013, UNSW Embryology ISBN: 978 0 7334 2609 4 - UNSW CRICOS Provider Code No. 00098G

 Leite MI, Jacob S, Viegas S, et al. (July 2008). "IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis" . Brain 131 (Pt 7): 1940–52.doi:10.1093/brain/awn092 . PMC 2442426.PMID 18515870

Page 96: Myasthenia gravis

REFERENCE ON THE HISTOLOGY

 Hill, M.A. (2013) Skeletal Muscle Histology. Retrieved October 1, 2013, from http://php.med.unsw.edu.au/embryology/index.php?title=Skeletal_Muscle_Histology

Dr Mark Hill 2013, UNSW Embryology ISBN: 978 0 7334 2609 4 - UNSW CRICOS Provider Code No. 00098G

 Leite MI, Jacob S, Viegas S, et al. (July 2008). "IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis" . Brain 131 (Pt 7): 1940–52.doi:10.1093/brain/awn092 . PMC 2442426.PMID 18515870

Page 97: Myasthenia gravis

THANK YOU………….